Brazil Veterinary Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Live Attenuated, Recombinant), By Animal Type (Swine, Fish, Poultry, Ruminants), And Segment Forecasts, 2020 - 2027

Report Overview

The Brazil veterinary vaccines market size to be valued at USD 707.8 million by 2027 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% during the forecast period. Rising mandates for vaccination to curb livestock disease outbreaks and increasing demand for livestock-related food products are primary factors expected to drive market growth.

The country ranked second in broiler meat production followed by the U.S. in 2019. The massive outbreak of COVID-19 in livestock producing countries, such as China and the U.S., is expected to increase Brazil’s meat export market. For instance, Brazilian livestock production is expected to increase by nearly 5% in 2020 due to COVID-19 pandemic.

Favorable government initiatives are likely to boost revenue growth. For instance, in May 2018, the World Organization for Animal Health declared Brazil, free of foot and mouth disease (FMD) with vaccination. The National Program for the Eradication and Prevention of FMD reduced the disease vaccine dose from 5 mL to 2 mL and aims to totally withdraw the vaccine by 2021.

Increasing companion animal population is further boosting the market growth. According to Abinpet report, there were around 52 million dogs in Brazil, highest in Latin America. Moreover, increasing trend of animal-assisted therapies is propelling the market growth. People with attention deficit disorder, autism spectrum disorder, Cerebral Vascular Accident (CVA) have reported benefits from animal-assisted therapies. The growing concern regarding pet health is further boosting the vaccine market.

Brazil Veterinary Vaccines Market Trends

The expanding prevalence of infectious and parasitic diseases, improved awareness of veterinarian healthcare, animal husbandry programs, and corresponding increase in animal ownership are driving up demand for veterinary vaccinations to prevent and treat diseases. In addition, severe effects of veterinary diseases on human health through reductions in the use of veterinary vaccines, their huge impact on safe meat production and its supply, and infection transmission from animal to human are factors expected to drive the demand for vaccination of vets.

Other factors expected to drive market expansion include technological developments in veterinary vaccines, increased demand for animal protein, issues about food safety, bacterial resistance, animal welfare, and a move from illness treatments to disease prevention. Furthermore, the rising prevalence of contagious diseases in poultry, increasing awareness, regulations by various governments to vaccinate vets, and product advances in the industry, are anticipated to create growth opportunities in the market.

Vaccines lose their targeted immunological qualities due to improper storage and transportation delays.   As a result, additional precautions need to be taken to retain their efficacy, which raises vaccine storage and transport costs. Thus, high vaccine storage costs are projected to result in higher costs for manufacturers, thus limiting the market expansion.

Product Insights

Live vaccines segment dominated the market in 2019 with a share of over 40% owing to increased usage in mass vaccination. Attenuated live vaccines have been used for decades and are the oldest immunization method against transmissible gastroenteritis coronavirus and porcine epidemic diarrhea virus. In 2017, Ceva launched CEVAC IBras-the first live attenuated vaccine-for addressing the Brazilian variant of avian infectious bronchitis virus. Recombinant vaccines are expected to witness the fastest CAGR over the forecast period.

This can be attributed to advantages of this vaccine, including lesser risk of pathogenicity and targeted action. Recombinant vaccines have shown efficacy against the Histophilus of some strain. The pathogen largely affects the cattle industry and is responsible for respiratory diseases, septicemia, reproductive tract disorders, infectious thrombotic meningoencephalitis, and pleuritic. Moreover, the vaccines are also effective in the treatment of Rhipicephalus microplus in Brazil, Argentina, Peru, Uruguay, Venezuela, and a few other Latin American countries.

Animal Type Insights

Ruminant segment led the market in 2019 accounting for a share of over 57%. Increasing cattle production and growing initiatives by the government to control sudden outbreak of diseases are the factors expected to propel the segment growth further. Brazil was the world’s second-largest cattle-producing country in 2019.

The major driver for cattle production is improved pastures condition and crossbreeding. The country became the top beef exporter in 2019, outpacing India. Moreover, the outbreak of African swine fever in Asia in 2017 also augmented the livestock production in the country. The lower cost of imported inputs, such as vaccines, due to favorable exchange rates is further fueling the growth of Brazil veterinary vaccines market.

Poultry segment is expected to witness the fastest growth during the forecast period due to high production of broiler meat in the country. It was the world’s second-largest country in broiler meat production in 2019. It produced around 13.8 million metric tons of broiler meat in 2019. It is also the top exporter of broiler meat worldwide. MAPA strongly regulates the vaccination program in the poultry industry to reduce the sudden outbreaks, which is further boosting the segment growth.

Key Companies & Market Share Insights

There are several foreign and domestic companies in the market. The country provides numerous growth opportunities to the market participants as it has the world’s largest cattle production. The companies have undertaken several strategic initiatives, such as merger & acquisitions, product launch, the establishment of new manufacturing facilities, and so on.

For example, in October 2018, Sumitomo Corp. entered into a strategic partnership with Ourofino Saúde Animal to expand its veterinary medicine business. In 2017, Ceva entered into the FMD vaccine market in Brazil by acquiring Hertape Saude Animale Ltda. and Inova Biotecnologia Saúde Animale Ltda. Boehringer Ingelheim acquired Merial in 2017, to increase its market penetration. Some of the prominent players in the Brazil veterinary vaccines market are:

• Zoetis, Inc.

• Ceva Santé Animale

• Boehringer Ingelheim

• MSD Animal Health

Brazil Veterinary Vaccines Market Report Scope

Brazil Veterinary Vaccines Market Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the Brazil veterinary vaccines market report on the basis of product and animal type:

• Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Live Attenuated Vaccines

  • DNA Vaccines

  • Recombinant Vaccines

  • Inactivated Vaccines

  • Others

• Animal Type Outlook (Revenue, USD Million, 2016 - 2027)

  • Poultry

    • Infectious Bronchitis

    • Avian Influenza

    • Marek's Disease

    • Newcastle Disease

    • Salmonella

    • Avian Encephalomyelitis

    • Fowl Cholera

    • Egg Drop Syndrome 76 (EDS 76)

    • Infectious coryza

    • Combined Vaccines

    • Others

  • Aqua

    • Streptococcosis

    • Vibrio

    • Aeromonas

    • Others

  • Ruminants

    • Foot & Mouth Disease (FMD)

    • Lumpy Skin

    • Rotavirus

    • Corona Virus

    • E. Coli

    • Bluetongue

    • Combined Vaccines

    • Others

  • Swine

    • Swine Influenza

    • Swine Fever

    • Parvovirus

    • PRRS

    • Foot & Mouth Disease

    • Others

  • Companion

    • Canine

      • Distemper

      • Kennel cough (Parainfluenza)

      • Parvovirus

      • Canine herpes

      • Lyme Disease

    • Feline

      • Rhinotracheitis

      • Calicivirus

      • Coronavirus

      • Panleukopenia